NK

Naresh Kanna Arcot Sekar

Active Director Director DIN 11239644
DIN 11239644 First appointment Aug 2025 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Kanna Arcot Sekar

Data last updated:

Naresh Kanna Arcot Sekar is a Director at Manjuchemtech India Private Limited (since 2025). The company operates in Chemicals.

DIN 11239644
Primary Designation Director
Industry Chemicals
First Appointment 13 Aug 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manjuchemtech India Private Limited U46691KA2024PTC186373
Director13 Aug 20252024Active

Board colleagues of Naresh Kanna Arcot Sekar

NameDINCompanyDesignation
Saravanan Jansirani10553980Manjuchemtech India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Manjuchemtech India Private Limited
Premium access

Shareholding and investment profile for Naresh Kanna Arcot Sekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kanna Arcot Sekar

Naresh Kanna Arcot Sekar currently holds 1 directorship: Manjuchemtech India Private Limited (Director, since 13 Aug 2025).

Naresh Kanna Arcot Sekar was first appointed on 13 Aug 2025 as Director at Manjuchemtech India Private Limited.

The current boards of Naresh Kanna Arcot Sekar's companies include Saravanan Jansirani (Manjuchemtech India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available